drugset / Trial / NCT01771198

Efficacy Study of SIMVASTATIN to Treat Chronic Rhinosinusitis After Failure of Optimal Treatment

NCT01771198

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the clinical efficacy of oral treatment with a statin, SIMVASTATIN 40mg, in a target population of patients with severe chronic rhinosinusitis resistant to surgery followed by conventional medical and surgical treatment.

Timeline

Start
2012-08
Primary completion
2015-07
Completion
2015-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 40 mg Oral

Indications